top of page

Spnib 100 mg Tablet

SKU Cadila Healthcare Ltd
Precio original

35,07$

Precio de oferta

33,85$

Spnib 100 mg Tablet is a targeted therapy that harnesses the power of dasatinib to combat specific cancer types, particularly chronic myeloid leukemia (CML), a malignancy that disrupts the normal production of white blood cells. By inhibiting certain proteins that promote cancer cell growth, this medication effectively helps in managing the progression of CML, offering hope to patients battling this challenging condition. It is crucial for patients to discuss their medical history with healthcare professionals, as Spnib may not be suitable for everyone and can have side effects, including potential interactions with other medications. Regular monitoring during treatment is recommended to ensure optimal efficacy and safety. As a vital option in the oncology arsenal, Spnib 100 mg Tablet represents a significant advancement in targeted cancer therapies, aiming to improve outcomes for those affected by this serious illness. Always follow your healthcare provider's guidance when using this medication to ensure the best possible results.

Cantidad

Active Pharmaceutical Ingredient

Dasatinib 100 mg

Uses

• Spnib 100 mg tablet is utilized in the management of chronic myeloid leukemia (CML), a cancer that primarily impacts the blood and bone marrow. Patients with CML often experience symptoms such as fatigue, weakness, and an enlarged spleen. The medication helps to control the proliferation of cancerous cells, contributing to better overall health and quality of life. Regular use of Spnib 100 mg tablet can lead to significant improvement in symptom management for individuals diagnosed with CML.
• In the treatment of acute lymphoblastic leukemia (ALL), Spnib 100 mg tablet plays a crucial role. This type of leukemia affects white blood cells and is known for its rapid progression. Patients may present with symptoms like easy bruising, shortness of breath, and frequent infections. By inhibiting the growth of malignant cells, Spnib 100 mg tablet aids in managing these symptoms effectively and can enhance the patient’s response to treatment.
• Spnib 100 mg tablet is also indicated for patients with specific hematological malignancies beyond CML and ALL. In cases where the disease is characterized by aggressive cell proliferation, this medication can help slow down the disease progression. It targets the underlying mechanisms of these cancers, thereby improving clinical outcomes. The use of Spnib 100 mg tablet is an integral part of a comprehensive treatment plan for patients facing these challenges.
• Healthcare providers often prescribe Spnib 100 mg tablet as part of a combination therapy regimen for patients with certain types of leukemia. This approach maximizes treatment efficacy and aims to reduce the risk of cancer recurrence. Spnib 100 mg tablet can work synergistically with other medications to enhance therapeutic effects. Patients receiving this treatment often report improvements in their overall well-being and a better capacity to manage the impact of their illness.

Benefits

Dasatinib 100 mg Tablet is effective and has a high rate of response in people with chronic myeloid leukemia (CML) and acute lymphoblastic leukemia. It decreases the number of cancer cells in the blood and bone marrow and improves blood counts in people with CML or ALL. Anti-cancer Drug Spnib is usually taken once a day, which may be more convenient for some people compared to other treatments. Spnib 100 mg is effective in people with CML or ALL who have not responded to other treatments.

Side Effects

Spnib 100 mg Tablet may cause some side effects. If you experience any of these side effects, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.

Most Common Side Effects

• Fever
• Nausea
• Nomiting
• Bleeding
• Skin rash
• Diarrhoea
• Infection
• Bone marrow suppression
• Pleural effusion
• Abdominal pain

Common Side Effects

• Difficulty breathing
• Headache
• Tiredness
• Fatigue
• Muscle and joint pain
• Swelling in the hands and feet

How To Use

Anti-cancer Drug Spnib may be taken with or without food. Take it at the same time each day. Swallow the tablet whole with a full glass of water. Do not crush, chew, or open the tablet. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.

Safety Advice

• Alcohol: Drinking alcohol while taking Spnib 100 mg is generally not recommended. It may increase the risk of liver damage and it is best to avoid alcohol or to limit the amount of alcohol you drink while you are taking this medicine.
• Kidney: Patients with kidney disease should closely monitor kidney function while taking Spnib 100 mg Tablet and report any unusual symptoms or changes in kidney function to their physician. The dose of Spnib 100 mg Pack should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Spnib 100 mg. Spnib 100 mg Pack may pass into breast milk and harm the infant. If you are breastfeeding and taking Spnib Tablet, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Spnib 100 mg Tablet should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Spnib 100 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Spnib Tablet may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Spnib 100 mg Tablet may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Anti-cancer Drug Spnib during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Spnib 100 mg Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Spnib 100 mg.

bottom of page